Skip to content

Role Of Mishreya Ark In Infantile Colic

Open Randomized Control Trial Of Mishreya Ark In Infantile Colic - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083117
Enrollment
68
Registered
2025-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system Health Condition 2: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

Dr Utkarsha Mohite
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with frequent complaint of continuous irritability, crying, fullness of abdomen, patients on breast feed, having weight appropriate for age

Exclusion criteria

Exclusion criteria: patients having congenital GI tract anomalies, organic abdominal diseases, history of GI tract surgeries, abnormal birth history, Patients not having weight appropriate for age

Design outcomes

Primary

MeasureTime frame
To determine efficacy of Mishreya Ark is effective in treatment of Infantile ColicTimepoint: 1st, 3rd, 5th day

Secondary

MeasureTime frame
To Compare efficacy of Mishreya Ark and Ajmoda Ark in Infantile ColicTimepoint: 1st, 3rd, 5th day

Countries

India

Contacts

Public ContactDr Deepika Patil

Hon. Shri Annasaheb Dange Ayurved Medical Collage Post Graduate And Research Center Ashta.

chaugulemahesh@gmail.com9921212722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026